These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38192989)

  • 1.
    Liang C; Chen Y; Chen S; She J; Shi Q; Wang P
    Transl Cancer Res; 2023 Dec; 12(12):3641-3652. PubMed ID: 38192989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
    Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
    PeerJ; 2023; 11():e15654. PubMed ID: 37520246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
    He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
    Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning immune-related gene based on KLRB1 model for predicting the prognosis and immune cell infiltration of breast cancer.
    Huang G; Xiao S; Jiang Z; Zhou X; Chen L; Long L; Zhang S; Xu K; Chen J; Jiang B
    Front Endocrinol (Lausanne); 2023; 14():1185799. PubMed ID: 37351109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
    Cheng X; Cao Y; Wang X; Cheng L; Liu Y; Lei J; Peng W; Shi D
    J Immunol Res; 2022; 2022():5254911. PubMed ID: 35028320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients.
    Du H; Zhang L; Chen J; Chen X; Qiang R; Ding X; Wang Y; Yang X
    Cancer Cell Int; 2024 Jan; 24(1):20. PubMed ID: 38195567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review.
    Li L; Hu Y; Li X; Ju B
    Medicine (Baltimore); 2024 Apr; 103(15):e37688. PubMed ID: 38608099
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Xu S; Xu Y; Chai W; Liu X; Li J; Sun L; Pan H; Yan M
    J Thorac Dis; 2024 Jun; 16(6):3764-3781. PubMed ID: 38983163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of
    Liu X; Cui Q; Qin N
    Transl Cancer Res; 2024 Mar; 13(3):1225-1240. PubMed ID: 38617516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying
    Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
    PeerJ; 2023; 11():e16618. PubMed ID: 38099311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-related gene
    Nong B; Su T; Jin M; Huang J; Huang A; Fang D; Wei J
    Transl Cancer Res; 2021 Jun; 10(6):2962-2976. PubMed ID: 35116604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer.
    Tang S; Zhang Y; Lin X; Wang H; Yong L; Zhang H; Cai F
    Oncol Lett; 2022 Aug; 24(2):285. PubMed ID: 35814828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
    Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
    Wei Q; Miao T; Zhang P; Jiang B; Yan H
    Front Genet; 2022; 13():984575. PubMed ID: 36159963
    [No Abstract]   [Full Text] [Related]  

  • 16. A bioinformatics analysis of the clinicopathological and prognostic significance of
    Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
    J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 18. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
    Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
    Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer.
    Gu J; Wang Z; Wang BO; Ma X
    Front Oncol; 2023; 13():1097015. PubMed ID: 36937436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.